Clinical trials
Terminated Phase 2 Skin Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
20 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2008 | 3 |
| 2009 | 2 |
| 2011 | 7 |
| 2013 | 1 |
| 2014 | 3 |
| 2015 | 1 |
| 2019 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 20 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 9 |
| Anne Chang | 1 |
| Apexigen America, Inc. | 1 |
| Celldex Therapeutics | 1 |
| DUSA Pharmaceuticals, Inc. | 1 |
| Dana-Farber Cancer Institute | 1 |
| M.D. Anderson Cancer Center | 1 |
| Memorial Sloan Kettering Cancer Center | 1 |
| New Mexico Cancer Research Alliance | 1 |
| Pfizer | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Skin Neoplasms | 20 |
| Melanoma | 15 |
| Neoplasm Metastasis | 2 |
| Neoplasms | 2 |
| Basal Cell Carcinoma | 1 |
| Basal Cell Nevus Syndrome | 1 |
| Carcinoma, Merkel Cell | 1 |
| Cutaneous Squamous Cell Carcinoma | 1 |
| Keratosis, Actinic | 1 |
Trials
Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.